Abrocitinib shows sustained efficacy in treating moderate to severe AD across multiple clinical and patient-reported outcome measures.

The pretreatment evaluation of patient-reported, health-related quality of life provides valuable prognostic information on ...

Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...

Steven Nathan, MD, continues a discussion surrounding the patient journey in through IPF treatment. What is the potential impact of these novel treatments on disease progression, mortality, and ...

Data from HAELO Phase 3 clinical trial presented today in a late-breaking oral session at European Academy of Allergy & ...

The American Academy of Sleep Medicine has developed and validated a patient-reported outcome tool for use in a clinical setting to monitor treatment response and longitudinal symptom progression in ...

Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...

Many patients with IBS and other functional GI disorders experience fragmentation of care and incur high costs. Can a virtual multidisciplinary model be the solution?

Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...